ghk-cu nasal spray Intra 50 mg/0.34 oz Ghk-Cu Intra Nasal Spray 50

Smith, S.R., et al

WHAT MAKES GHK-CU DIFFERENT

Quality and purity vary significantly between suppliers, making third-party testing verification essential

The mixed solution stirred for 30 min in a dark environment to reach adsorption equilibrium

Safety and Tolerability Cerebrolysin: Well-Established Safety Profile Cerebrolysin benefits from decades of post-marketing surveillance and clinical trial safety data: Clinical Trial Safety: Across multiple RCTs, Cerebrolysin has demonstrated a tolerability profile comparable to placebo in most studies, with adverse events generally mild and transient Common Side Effects: Injection site reactions, dizziness, headache, and nausea are the most frequently reported adverse events at standard clinical doses Serious Adverse Events: Rare at therapeutic doses